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Objectives: To investigate differences in participation with breast and cervical cancer 
screening related to individual socio-economic characteristics, across population-
based versus opportunistic screening programmes.   
Methods: Data from Eurobarometer 66.2 “Health in the European Union” 2006 on 
self-reported breast and cervical cancer screening participation in the preceding 12 
months within the EU 15 was obtained  The sample was restricted to those eligible for 
screening based on the screening age within each country. Observations for 2214 and 
5025 individuals respectively for breast and cervical cancer screening were available. 
Data on marital status, self-reported health, socio-economic group and years of 
education were also available. Screening programmes were categorised as population-
based or opportunistic and logistic regression analysis used to examine the 
relationship between participation, individual characteristics and programme type.   
Results: Differences in participation related to socio-economic status were observed 
in opportunistic screening programmes for breast cancer (OR=0.63* and OR=0.51**) 
and cervical cancer (OR=0.75** and OR=0.64**). Differences related to socio-
economic characteristics were not found with respect to participation in population-
based programmes.  
Conclusions: In opportunistic programmes, differences in participation across socio-
economic groups are evident in respect of both breast and cervical cancer screening. 
These differences may have implications for treatment and outcomes across socio-
economic groups. Such differences were not evident in population-based programmes.  
Keywords: Socio-economic, education, population-based screening, 
mammography, cervical screen. 
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Introduction 
In 2008 there were an estimated 3.2 million cases of cancer with over 1.7 million 
deaths from the illness in the European Union. Almost 500 000 of these cases related 
to breast or cervical cancer.[1] In recent years there has been both a collective and 
concerted effort by the European Union to combat cancer beginning with the Europe 
Against Cancer Action Plan in 1985.[2] More recently recommendations proposed by 
the European Commission focused upon the importance of early cancer detection 
through screening. Currently the European Partnership for Action Against Cancer 
2010 has emphasised the value of organised population-based screening, aimed at 100% 
of the target population for use in breast, cervical and colorectal screening.[3] The 
importance of organised cancer screening has been increasingly recognised in 
lowering mortality and morbidity in both cervical cancer and breast cancer.[4-6]  
 
Screening programmes differ in terms of their coverage and the manner in which they 
engage with the public. Programmes that offer universal coverage for eligible groups - 
where eligibility is based on an objectively assessed population risk – are typically 
characterised as population-based programmes. Such programmes not only use an 
objective risk assessment as the basis for eligibility but also adopt a systematic 
approach to the identification of eligible individuals who are contacted by the 
programme with invitations to participate. Opportunistic programmes by contrast rely 
to a greater extent on the subjective assessment of risk by the individual as well as the 
willingness and ability of the individual to take responsibility to organise a screening 
test. Differences in the role accorded the individual between the two programmes may 
contribute to differences in participation with screening as perceptions of risk as well 
as the willingness and ability of individuals to organise screening will vary with, for 
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example, socio-economic characteristics.  It has been argued by the EU and 
subsequently found in other studies that population-based programmes are more 
effective and equitable with respect to different socio-demographic groups.[7-10] In 
December 2003 the European Council, for example, advocated the development of 
national screening programmes with regard to a range of cancer screening services 
including breast, cervical and colorectal cancer.[7]  
 
Only one previous study has investigated differences in participation between 
programme types across EU countries related to individual characteristics. This used 
WHO (2002) cross country data from 22 countries within Europe to investigate 
variations across programme type with respect to educational attainment. It found 
differences related to education in opportunistic programmes but not in population-
based programmes.[11] Limitations exist with this study however. First, while it 
focuses on education, education is an imperfect indicator of social class and as such 
differences related to other individual characteristics may be missed.[12] Second, the 
data used in the study relate to 2002 which precede the EU Council recommendations 
and may not provide as current a picture of participation as more recent data. While 
other studies have found evidence of differential participation related to social class 
these have not examined differences across the types of programme offered or have 
used area based data and are thus open to accusations of ecological fallacy.[13-15] 
This study examines differences in participation across socio-economic classification 
controlling for other individual characteristics between population-based and 
opportunistic programmes using individual based data collected in 2006. To our 
knowledge it is the first study to do so using representative samples of individuals 
from across the EU-15.  
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Materials and Methods 
Data were extracted from a large population-based survey, Eurobarometer 66.2 
“Health in the European Union” for analysis. As noted in previous studies, 
population-based surveys offer the researcher a richer source of individual level data 
with which to explore differences in screening participation than are typically held in 
administrative data collected by screening programmes.[15] Data related to countries 
from the EU-15. While the EU Council has produced recommendations on the 
appropriate age range for screening, differences nevertheless exist between EU-15 
countries (see Table 1 & Table 2). To examine the impact of the programme the 
sample used for analysis was therefore restricted to individuals in the age ranges 
screened within each country for the cancer concerned. New accession states to the 
EU were not included in the study so as to reduce heterogeneity between states with 
respect to, for example, the maturity of the publicly funded health care system. The 
type of programme in each country was defined using data from the EU Council’s 
first report on the implementation of the 2003 Council Recommendations.[16]. The 
data extraction exercise produced 5025 individuals eligible based on age for 
participation in cervical cancer screening programmes and 2223 individuals eligible 
for participation in breast cancer screening .  
 
Eurobarometer uses a self-completed survey instrument. With respect to breast and 
cervical cancer screening respondents were asked: 
“Over the last 12 months, which, if any, of the following tests have you had? 
- Breast examination by X- ray, that is mammography 
- Cervical smear test, that is a pap smear” 
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Five socio-economic classes were constructed using the individual’s current or 
previous occupation: 
1)  Socio-economic group 1: Professionals; Business proprietors; High managerial 
positions. 
2)  Socio-economic group 2: Intermediate or junior managerial positions; State 
 employees. 
3)  Socio-economic group 3: Non Professionals; Semi-skilled. 
4)  Socio-economic group 4: Unskilled; Manual employee. 
5)  Socio-economic group 5: Individuals who never worked. 
 
Years of schooling was modelled using data on the age an individual finished their 
schooling. Individuals were only included in the analysis if they completed education 
after the age of nine and finished their formal education no later than 25 years of age. 
Five specific categories were created: 
1) Individuals who finished their schooling at 22 years or over. 
2) Individuals who finished between the ages of 19 and 21. 
3) Individuals who finished between the ages of 17 and 18. 
4) Individuals who finished between the ages of 15 and 16. 
5) Individuals who finished their schooling at 14 years or less. 
 
Other data extracted from the survey (selected based on its potential to impact upon 
participation in cancer screening) were: age, residence in urban or rural area, country  
of origin, marital status and self reported health. Dummy variables for each of the EU-
15 countries were included to control for differences across states. A multivariate 
logistic regression of participation as a function of the variables detailed was 
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undertaken. The analysis compared participation in screening across breast and 
cervical cancers, controlling for respondent socio-demographic characteristics, 
country and programme type classified using EU data.[17] (All variables are as 
defined in appendix 1.) 
 
Descriptive statistics on the samples, differences in participation rates related to socio-
demographic variables and by programmes type are reported in Table 1.1  Z-tests were 
used to determine the significance or otherwise of individual explanatory variables 
and WALD tests used to determine the joint significance of socio-economic variables. 
Regression coefficients are expressed as adjusted odds-rations to facilitate discussion.    
 
 
 
Results 
 
Table1(here) and Table2(here) outline the variations evident across the EU-15 
countries with regards to the organisation of screening programmes in terms of 
intervals and eligible ages for screening.[17] While differences in the targeted age 
range were small with respect to breast screening, as can be seen, larger differences 
existed with respect to cervical cancer screening. These differences within 
opportunistic programmes may consequently lead to adverse results regarding the 
efficacy and cost-effectiveness of the screening programme. 
 
Consistent with EU descriptions eight countries had completed full implementation of 
population-based breast cancer programmes by 2006. Five more countries had failed 
                                                 
1
 Population-based organised programmes offered screens to all individuals of target age groups within 
a country using a central cancer registry with adherence to correct interval periods. Opportunistic 
screening programmes conversely do not invite individuals to attend screening rather it is of the 
individuals or GPs initiative to attend for screens where correct interval periods may not be adhered to 
leading to over screening among certain women. Where population-based programmes are being 
implemented, opportunistic screening may still take place. 
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to achieve fully implemented population-based programmes but were in the process of 
doing so. Two countries Austria and Greece had only opportunistic programmes. With 
respect to cervical cancer screening five countries had implemented population-based 
programmes, (though the five had already implemented organised programmes prior 
to the EU recommendations of 2003). All others had yet to implement a population-
based programme (though Italy had begun to implement such a programme.)  
 
Table 3 (here) provides descriptive statistics and illustrates the participation rates 
across the EU-15. The table details participation across programme type for both 
cancers.  
 
Table 4 (here) presents the results of the multivariate analyses. These demonstrate that, 
with regards to breast cancer screening, there is a socio-economic gradient evident 
within the EU-15 countries that have not yet fully implemented organised 
programmes. With the highest socio-economic group operating as a base, those in 
socio-economic group 3 (OR=0.63*) and socio-economic group 5 (OR=0.51**) were 
significantly less likely to have had a mammogram in preceding 12 months compared 
to the most affluent group. (The Wald test for the socio-economic groups achieved 
borderline significance here also.) Education was found not to be a significant factor 
for either programme type. With regard to cervical cancer the results indicate that in 
countries with opportunistic programmes in place, those within the two lowest socio-
economic groups, are less likely to have had a screen compared to the most affluent 
group (OR=0.75**; OR=0.64**). (The Wald test was also significant for socio-
economic groups (P>chi=0.011)). Individuals with greater years of schooling had 
higher participation rates compared to individuals who finished formal education at 18 
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years or younger (OR=0.66***; OR=0.62***; OR=0.60***). (The Wald test was 
significant for age finished schooling groups (P>chi=0.000)). This suggests that years 
of schooling and socio-economic status play an important role in participation in 
cervical cancer screening in countries with opportunistic programmes. There are no 
such differences in countries with population-based screening programmes. Marital 
status was significant across both cancers and programme types. 
 
Discussion 
This study, demonstrates that a socio-economic gradient is evident in participation in 
both breast and cervical cancer screening in opportunistic programmes within EU-15 
countries but interestingly not in population-based programmes. Unlike the previous 
study which focused only on educational attainment, this study demonstrated the 
existence of such a gradient whilst controlling for years of schooling.[12] This 
measure of socio-economic status may be superior to education alone which may 
exhibit significant heterogeneity between countries and over time. (For example, what 
a given number of years of education or level of educational attainment means in 
terms of social class may vary between countries and overtime.) In opportunistic 
cervical screening programmes, socio-economic status and years of schooling were 
found to be highly significant factors in determining participation. This socio-
economic variation was not as evident in respect of breast cancer but was nevertheless 
present. In those countries with population-based screening programmes socio-
economic differences were not evident.  
 
For cervical cancer in particular, this is noteworthy given that those from lower socio-
economic groups exhibit a higher incidence of HPV infection, the major cause of 
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cervical cancer.[18] The EU Commission has issued recommendations that 
population-based programmes be implemented across the EU in accordance with 
IARC guidelines for breast, cervical as well as colorectal cancer screening. These 
programmes are more easily monitored; systematically evaluated and more cost 
effective.[8,19] Recent evidence suggests that that those countries that introduced 
organised nationwide screening programmes earliest are also those that have 
witnessed the largest declines in mortality over time.[20] This study demonstrates that 
population-based programmes may also avoid variations in participation related to 
socio-economic variables, an additional desirable outcome. While, as is evident from 
Table 3, a higher uptake of cervical screening services may occur in opportunistic 
programmes, this may reflect over use among those in higher social classes. Those 
from higher social classes may not only be more likely to use the service but use it 
with greater frequency. This may serve to compromise the cost effectiveness of the 
programme in the sense that screening may take place at shorter than appropriate 
intervals  while presenting a headline use figure that conceals low uptake among 
particular groups. The data available in the survey did not allow us to pursue this issue 
as it did not detail the interval since the last screen, merely whether there had been 
one in the preceding twelve months.   
 
The results for both breast and cervical cancer screening support the hypothesis that 
there are variations in participation related to socio-economic characteristics in 
opportunistic programmes. Between 2003 and the beginning of 2007, only three 
countries, in addition to those with existing programmes had completed the full 
implementation of organised screening for breast cancer whilst no country, without an 
existing programme had implemented organised screening for cervical cancer. This 
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suggests differences in participation related to social class are likely to persist at least 
in the short term and be reflected in differences in experience of morbidity and 
mortality across social classes. 
 
Barriers to the uptake of screening services may be financial or non-financial in nature. 
While opportunistic programmes may be more likely to have financial barriers 
associated with them (in that individuals may be more likely to pay for access) they 
may also have larger non-financial barriers in the sense that more of the burden of 
arranging a screen falls on the individual. The nature and impact of these barriers may 
differ between programmes. While the Eurobarometer provides a rich source of 
individual level characteristics it contains a relatively small number of observations 
for each country and a limited range of variables. This limits the extent to which 
analysis within and between countries including the nature and impact of particular 
barriers can be pursued. While the data source was rich the fact that household income 
was not, for example. collected limited our ability to ascertain the extent to which 
income played a role in screening  uptake within systems where charges may have 
been levied.. That there is heterogeneity between programmes classed here as either 
population-based or opportunistic is also conceded. Programmes will exist on a 
continuum in relation to their ability to overcome barriers to participation. The 
classification of programmes into population-based and opportunistic is recognised as 
being somewhat crude.  
 
Conclusion 
This study found that organised population-based screening programmes within the 
EU do not exhibit significant differences in screening participation across socio-
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economic groups. Moreover these differences are evident in opportunistic 
programmes. Population-based programmes may therefore allow for greater equality 
in respect of screening and associated benefits compared with opportunistic 
programmes. Further research on the nature of barriers to screening uptake and how 
best these might be overcome may facilitate the development of appropriate policy 
responses within programmes to address the socio-economic gradient evidenced here. 
Whether uptake from those in lower socio-economic classes would be better 
encouraged through education, financial incentives or greater persistence on the part 
of programmes when inviting individuals to screens is beyond the scope of this paper.     
However that compliance with EU recommendations in regard to population-based 
screening in breast and cervical may help reduce or eliminate socio-economic 
inequalities in participation and thereby reduce inequalities in morbidity and mortality 
does seem clear.  
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Table 1: Breast Cancer screening Programmes in the EU-15 
Breast Cancer Screening Programmes: 
Country Programme Type Rollout Status Eligible age Interval Period 
Austria 
 
Opportunistic 
 
- 
 
40+ 
 
2 
Belgium 
 
Organised 
 
Complete 
 
50-69 
 
2 
Denmark 
 
Organised 
 
Ongoing 
 
50-69 
 
2 
Finland* 
 
Organised 
 
Complete 
 
50-(59)69 
 
2 
France 
 
Organised 
 
Complete 
 
50-74 
 
2 
Germany 
 
Organised 
 
Ongoing 
 
50-69 
 
2 
Greece 
 
Opportunistic 
 
- 
 
40+ 
 
(1)2 
Republic of 
Ireland 
 
Organised 
 
Ongoing 
 
50-64 
 
2 
Italy 
 
Organised 
 
Ongoing 
 
50-69 
 
2 
Luxembourg 
 
Organised 
 
Complete 
 
50-69 
 
2 
Netherlands 
 
Organised 
 
Complete 
 
50-75 
 
2 
Portugal 
 
Organised 
 
Ongoing 
 
45-69 
 
2 
Spain* 
 
Organised 
 
Complete 
 
(45)50-64(70) 
 
2 
Sweden* 
 
Organised 
 
Complete 
 
40(50)-(69)70 
 
2 
UK (Great 
Britain) 
 
Organised 
 
Complete 
 
50-70 
 
3 
UK (Northern 
Ireland) 
 
Organised 
 
Complete 
 
50-64 
 
3 
† Data acquired from von Karsa et al (2008) Cancer screening in the European Union. Report on the 
implementation of the Council Recommendation on cancer screening – First Report. European 
Commission, 2008. http://ec.europa.eu (date last accessed 26 March 2010). 
*In Finland, Spain and Sweden variations in eligible ages groups between regions within the country.  
- The EU recommends targeting of women aged 50-69 
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Table 2: Cervical Cancer Screening Programmes in the EU-15 
† Data acquired from von Karsa et al (2008) Cancer screening in the European Union. Report on the 
implementation of the Council Recommendation on cancer screening – First Report. European 
Commission, 2008. http://ec.europa.eu (date last accessed 26 March 2010). 
*In Finland, France and Spain, variations in eligible ages groups between regions within the country. 
- The EU recommends targeting of women not before the age of 20, and not after the age of 30. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cervical Cancer Screening Programmes: 
Country Programme Type Rollout Status Eligible age Interval 
Period 
Austria 
 
Opportunistic 
 
- 
 
18+ 
 
1 
Belgium 
 
Opportunistic 
 
- 
 
25-64 
 
3 
Denmark 
 
Organised 
 
Complete 
 
23-59 
 
3&5 
Finland* 
 
Organised 
 
Complete 
 
(25)30-60(65) 
 
5 
France* 
 
Opportunistic 
 
- 
 
(20)25-65 
 
3 
Germany 
 
Opportunistic 
 
- 
 
20+ 
 
1 
Greece 
 
Opportunistic 
 
- 
 
20+ 
 
1 
Republic of 
Ireland 
 
Opportunistic 
 
- 
 
25-60 
 
3&5 
Italy 
 
Organised 
 
Ongoing 
 
25-64 
 
3 
Luxembourg 
 
Opportunistic 
 
- 
 
15+ 
 
1 
Netherlands 
 
Organised 
 
Complete 
 
30-60 
 
5 
Portugal 
 
Opportunistic 
 
- 
 
25-64 
 
3 
Spain* 
 
Opportunistic 
 
- 
 
(18)30(35)-59(65) 
 
3 or 5 
Sweden 
 
Organised 
 
Complete 
 
23-60 
 
3&5 
UK (Great 
Britain) 
 
Organised 
 
Complete 
 
25-70 
 
3&5 
UK (Northern 
Ireland) 
 
Organised 
 
Complete 
 
20-64 
 
3&5 
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Table 3: Descriptive Statistic of cancer screening participation in the previous 12 
months 
                                                Breast                             Cervical             
  Opportunistic or 
not fully rolled 
out organised 
Organised & 
fully rolled out 
Opportunistic Organised & fully 
rolled out 
Overall  % 53% 58% 55% 41% 
Age group 
20-29 
 
- 
 
 
- 
 
55% 
 
46% 
30-39 - 
 
- 57% 48% 
40-49 74% 
 
- 60% 
 
45% 
50-59 58% 
 
65% 
 
59% 34% 
60-69 45% 
 
59% 
 
48% 26% 
70-74 29% 47% 
 
- - 
Socio-economic group 
Professionals; Business 
owners; Higher managers 
 
64% 
 
55% 
 
61% 
 
41% 
Intermediate managerial; 
junior non-manual 
52% 63% 60% 44% 
Non Professionals, Service 
job; State job 
51% 53% 59% 36% 
Semi-skilled 
 
53% 58% 48% 38% 
Never worked 48% 57% 44% 38% 
Age finished schooling 
Ages 22-25 
 
44% 
 
60% 
 
63% 
 
45% 
Ages 19-21 57% 66% 62% 44% 
Ages 17-18 57% 56% 56% 38% 
Ages 15-16 51% 52% 54% 36% 
Ages 10-14 53% 59% 42% 26% 
Marital Status 
Married 
 
57% 
 
65% 
 
59% 
 
43% 
Single, divorced or 
widowed 
 
47% 
 
48% 
 
48% 
 
37% 
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Table 4: Multivariate Analysis using Logistic Odds Ratios and Wald joint 
significance statistic 
Standard errors in brackets. 
*     significant to the 90 percentile; **   significant to the 95 percentile; *** significant to the 99 
percentile 
                                               Breast                               Cervical             
  Opportunistic or 
not fully rolled 
out organised 
1196 
Organised & 
fully rolled out 
 
1027 
Opportunistic 
 
 
3689 
Organised & 
fully rolled out 
 
1336 
Age group 
20-29 
 
- 
 
 
- 
 
0.73** 
(0.10) 
 
2.00** 
(0.48) 
30-39 - - 0.86 
(0.09) 
1.97*** 
(0.32) 
40-49 0.89 
(0.27) 
- 1.01 
(0.10) 
1.76*** 
(0.28) 
50-59 1 1 1 1 
60-69 0.61*** 
(0.08) 
0.77* 
(0.11) 
0.54*** 
(0.07) 
0.88 
(0.21) 
70-75 0.14*** 
(0.07) 
0.32*** 
(0.10) 
0.18*** 
(0.07) 
- 
Socio-economic group 
Professionals; Business owners; 
Higher managers.  
 
1 
 
1 
 
1 
 
1 
Intermediate managerial; junior 
non-manual. 
0.69 
(0.16) 
1.12 
(0.26) 
0.91 
(0.11) 
1.11 
(0.22) 
Non Professionals, Service job; 
State job. 
0.63* 
(0.15) 
0.75 
(0.18) 
0.95 
(0.12) 
0.81 
(0.17) 
Semi-skilled. 0.73 
(0.17) 
0.90 
(0.22) 
0.75** 
(0.09) 
0.94 
(0.21) 
Have never worked. 0.51** 
(0.14) 
1.03 
(0.34) 
0.64*** 
(0.09) 
0.86 
(0.40) 
Health 
Fair or poor 
 
1 
 
1 
 
1 
 
1 
Good or excellent 1.02 
(0.14) 
1.01 
(0.15) 
1.19** 
(0.11) 
1.13 
(0.17) 
Age finished schooling 
22-25 
 
1 
 
1 
 
1 
 
1 
19-21 1.18 
(0.32) 
1.36 
(0.37) 
0.87 
(0.11) 
1.11 
(0.18) 
17-18 0.91 
(0.22) 
1.06 
(0.27) 
0.66*** 
(0.08) 
0.87 
(0.16) 
15-16 0.71 
(0.18) 
1.04 
(0.28) 
0.62*** 
(0.08) 
0.90 
(0.17) 
10-14 0.86 
(0.23) 
1.61 
(0.47) 
0.60*** 
(0.08) 
0.70 
(0.27) 
Marital Status 
Single, divorced or widowed. 
 
1 
 
1 
 
1 
 
1 
Married. 1.35** 
(0.16) 
1.61*** 
(0.23) 
1.42** 
(0.10) 
1.42** 
(0.1442) 
Wald Test Statistic 
socio-economic group. 
chi2(4) =   6.90 
P>chi2 =    0.141 
chi2(4) =    5.11 
P> chi2 =   0.270 
chi2(4) =   12.90 
P> chi2=   0.011 
chi2(4) =    4.82 
P> chi2 =   0.306 
Wald Test Statistic 
f age finished schooling. 
chi2(4) =   4.16 
P>chi2 =    0.384 
chi2(4) =    6.46 
P> chi2 =   0.167 
chi2(4) =   18.33 
P> chi2=   0.000 
chi2(4) =    2.07 
P> chi2 =   0.557 
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Appendix 
  
The variables presented in this study were based upon data from the EU-15 member 
states in the large population-based survey Eurobarometer “Health in the European 
Union” 66.2 (2006). This Eurobarometer was carried out at the end of 2006 and 
surveyed participants on whether they had a breast or cervical cancer test in the 
previous 12 months. Data was restricted to individuals in the age range screened 
within each individual country as these ages varied within the EU-15 countries. 
 
Table A1: Variable Definition and sources 
Variable Definition 
Socio-economic groups Within the Eurobarometer “Health in the European 
Union” 66.2 (2006) dataset, individuals were 
categorised into 19 distinctive occupations. Five 
socio-economic groups were constructed using an 
individual’s current or previous occupation from this 
occupation scale. 
1) Socio-economic group 1 Professional (lawyer, medical practitioner, 
accountant, architect); Business proprietors, owner 
(full or partner) of a company; Owner of a shop, 
craftsmen; Employed professional (employed doctor, 
lawyer, accountant, architect); General management, 
director or top management (managing directors, 
director general, other director). 
2) Socio-economic group 2 Middle management, other management (department 
head, junior manager, teacher, technician); Employed 
position, in a service job (hospital, restaurant, police, 
fireman). 
3) Socio-economic group 3 Employed position at a desk; Employed position, not 
at travelling (salesmen, driver). 
4) Socio-economic group 4 Agriculture worker; Lower supervisor; Manual 
worker; Unskilled worker. 
5) Socio-economic group 5 Never did any paid work. 
Years of schooling The survey questioned an individual about the year 
they left full time education. Individuals who left 
before the age of ten and those who continued after 
the age of 25 were excluded from analysis. 
1) Age 10-14 Finished schooling aged 14 or less. 
2) Age 15-16 Finished schooling between the ages of 15 and 16. 
3) Age 17-18 Finished schooling between the ages of 17 and 18. 
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4) Age 19-21 Finished schooling between the ages of 19 and 21. 
5) Age 22-25 Finished schooling aged 22 or more. 
Age group of individual Using the exact age, Individuals were categorised 
into 5 yearly age groups. 20-24; 25-29; 30-34; 35-39; 
40-44; 45-49; 50-54; 55-59; 60-64; 65-69 and 70-74 
Marital status A dichotomous variable was constructed for marital 
status. If the individual was married a value of 1 was 
assigned. If the individual was single, divorced or 
widowed a value of 0 was assigned. 
1) Married An individual is married. 
2) Single, divorced or  
widowed 
An individual is single, divorced or widowed 
Self reported health Eurobarometer enquired about the self reported 
health of the individual. A dichotomous variable was 
constructed. If the individual reported very good or 
good general health a value of 1 was assigned. If the 
individual reported fair, bad or very bad a value of 0 
was assigned.  
1) Very good or good An individual reports general health to be very good 
or good 
2) Neither good nor bad, 
bad or very bad 
An individual reports general health to be neither 
good nor bad, bad or very bad 
Urban or rural Eurobarometer asked whether the individual lived in 
a rural area or village, small town or large town. A 
dichotomous variable was constructed. If an 
individual lived in a small town or large town a value 
of 1 was assigned. If an individual lived in a rural 
area or village a value of 0 was assigned 
1) Urban An individual lives in a small or large town 
2) Rural An individual lives in a rural area or village 
Country of residence Individuals were questioned with regards to whether 
they were born in the country in which they 
currently lived. A dichotomous variable was 
constructed. If an individual was born within the 
country of residence a value of 1 was assigned. If an 
individual was born outside the country of residence 
a value of 0 was assigned. 
1) Born in resident country An individual was born within the country of 
residence 
2) Immigrant An individual was born outside the country of 
residence 
 
 
 
 
 
 
